382.29999 EUR
3.9
1.03%
Last update Dec 12, 11:13 AM CET
Main market
Day range
379.60001
382.29999
Previous close
378.39999
Open
379.60001
Access this stock data via API
Subscribe
Vertex Pharmaceuticals Inc.
382.30
3.90
1.03%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 9.4B 9.9B 8.9B 7.6B
Cost of revenue 1.3B 1.3B 1.1B 904.2M
Gross profit 8.1B 8.6B 7.9B 6.7B
Operating expense
Research & development 7.0B 3.7B 2.7B 3.1B
Selling general and admin 1.2B 1.1B 944.7M 840.1M
Other operating expenses
Operating income -198.9M 3.8B 4.2B 2.8B
Non operating interest income
Income 509.7M 614.7M 144.6M 4.9M
Expense 26.1M 44.1M 54.8M 61.5M
Other income expense -73.0M 28.8M -107.3M 8M
Pretax income 211.8M 4.4B 4.2B 2.7B
Tax provision 668.2M 760.2M 910.4M 388.3M
Net income -456.5M 3.6B 3.3B 2.3B
Basic EPS -2.1 14.1 13.0 9.1
Diluted EPS -2.1 13.9 12.8 9.0
Basic average shares 219.8M 268.2M 266.5M 268.2M
Diluted average shares 219.8M 268.2M 266.5M 268.2M
EBITDA 414.0M 4.6B 4.4B 2.9B
Net income from continuing op. -456.5M 3.6B 3.3B 2.3B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 6 minutes

12:53
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).